Publicaciones en colaboración con investigadores/as de Universidade Federal do Espírito Santo (5)

2024

  1. Long-term efficacy and safety of a tetravalent dengue vaccine (TAK-003): 4·5-year results from a phase 3, randomised, double-blind, placebo-controlled trial

    The Lancet Global Health, Vol. 12, Núm. 2, pp. e257-e270

2022

  1. Efficacy of a Dengue Vaccine Candidate (TAK-003) in Healthy Children and Adolescents 2 Years after Vaccination

    Journal of Infectious Diseases, Vol. 225, Núm. 9, pp. 1521-1532

  2. Investigation of Leishmania (Viannia) braziliensis Infection in Wild Mammals in Brazil

    Acta Parasitologica, Vol. 67, Núm. 2, pp. 648-657

  3. Three-year Efficacy and Safety of Takeda's Dengue Vaccine Candidate (TAK-003)

    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, Vol. 75, Núm. 1, pp. 107-117

2019

  1. Efficacy of a tetravalent dengue vaccine in healthy children and adolescents

    New England Journal of Medicine, Vol. 381, Núm. 21, pp. 2009-2019